People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Xenetic Biosciences, Inc. | — | Biotechnology | Series A | $17.6M | $5.9M | 2019 |
Roman Knyazev at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Roman Knyazev on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Roger Kornberg | 1 | 4 |
| Jeffrey Eisenberg | 1 | 4 |
| Curtis Lockshin | 1 | 3 |
| Grigory Borisenko | 1 | 3 |
| James Parslow | 1 | 2 |
| ADAM LOGAL | 1 | 2 |
| Alexey Vinogradov | 1 | 2 |
| Firdaus Dastoor | 1 | 1 |
| James Callaway | 1 | 1 |
| Dmitry Genkin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.